One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy-and an aggressive type of blood cancer called acute myeloid leukemia (AML) is notorious for this.
RUNX1C isoform identified as driver of chemoresistance in acute myeloid leukemia
- Post author:admin
- Post published:August 17, 2025
- Post category:uncategorized